Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
Galderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreGalderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreGalderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft®, a...
Read MoreThe U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates...
Read MoreThe U.S. Food and Drug Administration approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part...
Read MoreHistogen, a regenerative medicine company focused on stimulating the body’s stem cells to regenerate tissues and restore youthful function, has received approval of its Investigational New Drug (IND) application from...
Read MoreAllergan plc announced the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA® Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision...
Read MoreAllergan announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market 28 additional styles of Natrelle® 410 silicone-filled breast implants, giving surgeons and patients more...
Read MoreNow indicated for Correction of Age Related Volume Loss in the Cheek Area. Galderma, a global healthcare company focused on skin health, announced today that it has received US Food...
Read More